Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma

NCT00064779 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Glioma
Glioblastoma Multiforme
Anaplastic Astrocytoma
Anaplastic Oligodendroglioma
Mixed Oligoastrocytoma

Interventions

DRUG: IL13-PE38QQR
PROCEDURE: targeted fusion protein therapy
PROCEDURE: surgery

Sponsor

INSYS Therapeutics Inc